Revolution Medicines Inc (RVMD) — 13F Filings Explorer (Q2 2026)

RVMD ranks #778 out of 37696 tracked stocks by institutional interest — one of the most closely watched names in our coverage.

RVMD is a top-conviction position for Nextech Invest Ltd. — at 67.5% of their entire disclosed 13F portfolio, it's one of their largest single bets, not just a passing allocation.

The largest dollar stake in RVMD belongs to BlackRock, Inc., but the position matters far more to Nextech Invest Ltd., who has 67.5% of their own portfolio riding on it — a reminder that the biggest holder by size and the holder with the biggest bet aren't always the same fund.

Fjarde Ap-fonden /fourth Swedish National Pension Fund has added to its RVMD position for two straight quarters, increasing it by $6.6M to reach $11.2M today.

RVMD is down 6% today, but institutions show net buying of $9.7B this quarter — a divergence between today's price move and the underlying institutional flow.

RVMD reported a net loss of $1.8B over the trailing twelve months.

• Not yet profitable — net loss of $1.8B over the trailing twelve months
• Revenue declined 100.0% year over year
• Net income declined year over year, from -$812.1M to -$1.8B
• Operating cash flow was negative, using $897.7M in cash
• Current ratio of 7.14x — enough short-term assets to cover short-term liabilities
• Liabilities run 0.44x equity — within a conventional range